To this end, CRISPR Therapeutics is currently managing five other clinical trials, with several more pre-clinical studies ...

UK investors have enjoyed spectacular returns in their Stocks and Shares ISA's over the past five years. Would could the next ...

It's a dangerous world, and this is driving up defense stock prices. For new investors looking to buy, this is not a good thing.